Cite
HARVARD Citation
Hirabayashi, Y. et al. (2016). Clinical and structural remission rates increased annually and radiographic progression was continuously inhibited during a 3-year administration of tocilizumab in patients with rheumatoid arthritis: A multi-center, prospective cohort study by the Michinoku Tocilizumab Study Group. Modern rheumatology. 26 (6), pp. 828-835. [Online].